Page 19 - Research Database News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Widespread EHR adoption provides rich source of patient data for Covid-19 research Widespread EHR adoption provides rich source of patient data for Covid-19 research Data captured in EHR systems provide near real-time information about the nationwide vaccine rollout, help monitor potential safety issues, and foster understanding of the Covid-19 virus, treatments and associated outcomes in real-world care settings. Shares0 In the all-hands-on deck race to conquer the coronavirus pandemic, de-identified patient data from a variety of sources support clinical research, and near real-time data c...

Our risk model estimates chances of death and hospitalisation based on age, sex and comorbidities

Today, the NYU Stern Center for Sustainable Business, partnering with Rockefeller Asset Management, announced the findings from a new meta-study examining the relationship between environmental, social and corporate governance (ESG) activities at organizations and their financial performance.

Prognos Health Caps Off Innovative Year With Award prognosFACTOR™ named one of the most innovative products of 2020 by PM360 News provided by Share this article NEW YORK, Dec. 16, 2020 /PRNewswire/ --  Prognos Health, a leading clinically-focused healthcare analytics company, finishes a record year of new products and new partnerships with an award for product innovation. This month PM360, a leading magazine for decision makers in the pharmaceutical, biotech, medical device and diagnostics industries, named  "Seeing prognosFACTOR receive this recognition is the culmination of a remarkable...

by John Klyczek / December 14th, 2020 Five of the pharmaceutical companies developing COVID-19 vaccines through the USA’s Operation Warp Speed have paid out a total of nearly $6 billion to settle lawsuits charging them with fraud related to “off-label” marketing of atypical antipsychotics and antidepressants that were mandated through the Texas Medication Algorithm Project (TMAP), which evolved into President George W. Bush’s federal “New Freedom Commission on Mental Health.” AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Janssen Pharmaceutical, and Pfizer, which are currently f...